HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Donald C Sheppard Selected Research
Donald C Sheppard Research Topics
Disease
21
Infections
01/2022 - 07/2004
10
Aspergillosis
10/2021 - 04/2004
5
Invasive Fungal Infections
01/2022 - 08/2005
5
Invasive Pulmonary Aspergillosis
01/2022 - 01/2009
4
Pulmonary Aspergillosis
01/2022 - 07/2015
4
Mycoses (Diseases, Fungus)
01/2022 - 04/2016
4
Inflammation (Inflammations)
01/2021 - 01/2016
4
Candidiasis (Moniliasis)
04/2016 - 04/2005
2
Candidemia
01/2022 - 09/2021
2
Neutropenia
01/2022 - 08/2008
2
HIV Infections (HIV Infection)
01/2020 - 04/2006
2
Cryptococcosis
04/2019 - 01/2017
2
autosomal recessive Candidiasis familial chronic mucocutaneous
04/2016 - 07/2014
2
Hematologic Neoplasms (Hematological Malignancy)
10/2010 - 05/2010
2
Autoimmune Diseases (Autoimmune Disease)
05/2010 - 08/2005
1
Cross Infection (Nosocomial Infection)
12/2021
1
Coinfection
10/2021
1
Invasive Candidiasis
09/2021
1
Atherosclerosis
01/2021
1
Coronary Artery Disease (Coronary Atherosclerosis)
01/2021
1
Pneumonia (Pneumonitis)
01/2021
1
Vascular Diseases (Vascular Disease)
01/2021
1
Atherosclerotic Plaque (Atheroma)
01/2021
1
Acquired Immunodeficiency Syndrome (AIDS)
01/2020
1
Disease Progression
01/2020
1
Thrombocytopenia (Thrombopenia)
01/2020
1
Thrombosis (Thrombus)
01/2020
1
Neoplasms (Cancer)
01/2020
1
Starvation
12/2019
1
Mucormycosis
11/2019
1
Leukemia
01/2017
1
Marginal Zone B-Cell Lymphoma (MALT Lymphoma)
04/2016
1
Lymphoma (Lymphomas)
04/2016
1
Hallucinations (Hallucination)
02/2016
1
Chronic Granulomatous Disease
01/2016
Drug/Important Bio-Agent (IBA)
5
Cytokines
IBA
01/2021 - 08/2008
4
Echinocandins
IBA
01/2022 - 04/2006
4
posaconazole
FDA Link
10/2021 - 02/2016
3
Glycoside Hydrolases (Endoglycosidases)
IBA
12/2021 - 01/2018
3
Voriconazole (Vfend)
FDA Link
Generic
09/2021 - 05/2010
3
galactosaminogalactan
IBA
12/2019 - 01/2013
3
liposomal amphotericin B
FDA Link
11/2019 - 10/2006
3
Proteins (Proteins, Gene)
FDA Link
04/2016 - 07/2004
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2009 - 08/2005
2
Enzymes
IBA
12/2021 - 01/2018
2
Antifungal Agents
IBA
10/2021 - 01/2021
2
Azoles
IBA
09/2021 - 07/2015
2
Polysaccharides (Glycans)
IBA
01/2021 - 08/2017
2
Caspofungin (Cancidas)
FDA Link
11/2020 - 05/2010
2
Fungal Polysaccharides
IBA
01/2020 - 08/2017
2
Mycotoxins
IBA
01/2020 - 08/2008
2
Transcription Factors (Transcription Factor)
IBA
12/2019 - 11/2010
2
galactomannan
IBA
04/2019 - 10/2010
2
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
04/2016 - 07/2014
2
Micafungin (FK463)
FDA Link
07/2015 - 04/2006
2
Virulence Factors (Pathogenicity Factors)
IBA
01/2013 - 08/2008
2
E-Selectin
IBA
01/2009 - 08/2008
2
Interleukin-8 (Interleukin 8)
IBA
01/2009 - 08/2008
1
guanosine 5'-monophosphorothioate
IBA
01/2022
1
Oxygen (Dioxygen)
IBA
01/2022
1
Triazoles
IBA
09/2021
1
Fluconazole (Zonal)
FDA Link
Generic
09/2021
1
Amphotericin B (Amphotericin)
FDA Link
Generic
09/2021
1
lipoxin A4
IBA
01/2021
1
oxidized low density lipoprotein
IBA
01/2021
1
Apolipoproteins
IBA
01/2021
1
Apolipoproteins E (ApoE)
IBA
01/2021
1
Cholesterol
IBA
01/2021
1
Glycolipids
IBA
01/2021
1
Glycoproteins (Glycoprotein)
IBA
01/2021
1
Interleukin-1 (Interleukin 1)
IBA
01/2021
1
LDL Lipoproteins (beta Lipoproteins)
IBA
01/2021
1
Neuraminidase (Sialidase)
IBA
01/2021
1
LDL Receptors (LDL Receptor)
IBA
01/2021
1
Interleukin-1 Receptors (Interleukin 1 Receptor)
IBA
01/2021
1
N-Acetylneuraminic Acid (Sialic Acid)
IBA
01/2021
1
Asialoglycoprotein Receptor
IBA
01/2021
1
Apolipoprotein B-100 (Apo B 100)
IBA
01/2021
1
Anaphylatoxins
IBA
01/2020
1
Galectin 3 (LGALS3)
IBA
01/2020
1
Lipopolysaccharides
IBA
01/2020
1
Fungal Antigens
IBA
01/2020
1
Complement System Proteins (Complement)
IBA
01/2020
1
Iron
IBA
12/2019
1
galactoxylomannan
IBA
04/2019
1
Pharmaceutical Preparations
IBA
04/2019
1
Solutions
IBA
01/2018
1
Interleukin-1beta (Interleukin 1 beta)
IBA
01/2017
1
Interleukin-1alpha (Interleukin 1 alpha)
IBA
01/2017
1
Interleukin-1 Type I Receptors
IBA
01/2017
1
ras-GRF1 (ras GRF1)
IBA
04/2016
1
Chemokines
IBA
09/2015
1
Interleukin-17 (Interleukin 17)
IBA
09/2015
Therapy/Procedure
8
Therapeutics
01/2022 - 07/2014
2
Catheters
12/2021 - 07/2008
1
Central Venous Catheters
12/2021
1
Art Therapy
01/2020
1
Lasers (Laser)
04/2019
1
Aftercare (After-Treatment)
04/2019
1
Stem Cell Transplantation
11/2016